Lexaria Bioscience (LEXX) Payables (2011 - 2026)
Lexaria Bioscience's Payables was $350,377 in fiscal Q3 2026 (quarter ended May 31, 2026), down 76.0% from $1.46 million a year earlier but up 91.9% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), Payables at Lexaria Bioscience came in at $1.46 million, up 37.2% from FY2024.
- Payables has now increased for five consecutive fiscal years, with a five-year compound annual growth rate of 75.9% (FY2020 to FY2025).
- In earlier fiscal years, Payables was $1.07 million in FY2024 (+344.4%), $239,941 in FY2023 (+58.4%), $151,449 in FY2022 (+42.9%) and $105,946 in FY2021 (+21.9%).
- Quarterly Payables has moved between $55,318 (fiscal Q2 2024) and $1.79 million (fiscal Q2 2025) over five years.
- Compared with a year earlier, Payables was higher in four of the last six quarters, with growth averaging 136.3%.
- The best year-over-year quarter for Payables over five years was fiscal Q3 2023 (growth of 551.6%); the worst was fiscal Q2 2026 (a decline of 89.8%).
- Per Business Quant data, LEXX's Payables in the three fiscal quarters before Q3 2026 was $182,611 (Q2 2026), $1.43 million (Q1 2026) and $1.46 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Lexaria Bioscience | 3.30 Mn | -12.35 Mn | - | 350,377.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 350,377.00 |
| Feb 28, 2026 | 182,611.00 |
| Nov 30, 2025 | 1.43 Mn |
| Aug 31, 2025 | 1.46 Mn |
| May 31, 2025 | 1.46 Mn |
| Feb 28, 2025 | 1.79 Mn |
| Nov 30, 2024 | 268,986.00 |
| Aug 31, 2024 | 1.07 Mn |
| May 31, 2024 | 128,788.00 |
| Feb 29, 2024 | 55,318.00 |
| Nov 30, 2023 | 98,969.00 |
| Aug 31, 2023 | 239,941.00 |
| May 31, 2023 | 1.02 Mn |
| Feb 28, 2023 | 189,776.00 |
| Nov 30, 2022 | 241,891.00 |
| Aug 31, 2022 | 151,449.00 |
| May 31, 2022 | 157,095.00 |
| Feb 28, 2022 | 116,592.00 |
| Nov 30, 2021 | 189,542.00 |
| Aug 31, 2021 | 105,946.00 |
API Access
Lexaria Bioscience Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();